1. Home
  2. ILMN vs SBAC Comparison

ILMN vs SBAC Comparison

Compare ILMN & SBAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • SBAC
  • Stock Information
  • Founded
  • ILMN 1998
  • SBAC 1989
  • Country
  • ILMN United States
  • SBAC United States
  • Employees
  • ILMN N/A
  • SBAC N/A
  • Industry
  • ILMN Medical Specialities
  • SBAC Real Estate Investment Trusts
  • Sector
  • ILMN Health Care
  • SBAC Real Estate
  • Exchange
  • ILMN Nasdaq
  • SBAC Nasdaq
  • Market Cap
  • ILMN 23.6B
  • SBAC 24.0B
  • IPO Year
  • ILMN 2000
  • SBAC 1999
  • Fundamental
  • Price
  • ILMN $147.64
  • SBAC $216.21
  • Analyst Decision
  • ILMN Buy
  • SBAC Buy
  • Analyst Count
  • ILMN 19
  • SBAC 14
  • Target Price
  • ILMN $162.67
  • SBAC $257.07
  • AVG Volume (30 Days)
  • ILMN 2.1M
  • SBAC 741.8K
  • Earning Date
  • ILMN 02-06-2025
  • SBAC 10-28-2024
  • Dividend Yield
  • ILMN N/A
  • SBAC 1.81%
  • EPS Growth
  • ILMN N/A
  • SBAC 39.29
  • EPS
  • ILMN N/A
  • SBAC 6.34
  • Revenue
  • ILMN $4,390,000,000.00
  • SBAC $2,660,958,000.00
  • Revenue This Year
  • ILMN N/A
  • SBAC N/A
  • Revenue Next Year
  • ILMN $4.28
  • SBAC $2.94
  • P/E Ratio
  • ILMN N/A
  • SBAC $34.12
  • Revenue Growth
  • ILMN N/A
  • SBAC N/A
  • 52 Week Low
  • ILMN $97.36
  • SBAC $183.64
  • 52 Week High
  • ILMN $156.66
  • SBAC $258.76
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 56.37
  • SBAC 37.06
  • Support Level
  • ILMN $138.88
  • SBAC $216.09
  • Resistance Level
  • ILMN $151.75
  • SBAC $225.06
  • Average True Range (ATR)
  • ILMN 4.96
  • SBAC 3.94
  • MACD
  • ILMN 0.76
  • SBAC -0.11
  • Stochastic Oscillator
  • ILMN 81.01
  • SBAC 11.21

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About SBAC SBA Communications Corporation

SBA Communications owns and operates almost 40,000 cell towers throughout North America, South America, and Africa. It leases space on its towers to wireless service providers, which install equipment on the towers to support their wireless networks. The company has a very concentrated customer base, with most revenue in each market being generated by just the top few mobile carriers. It owns more than 17,000 towers in the US, which accounted for about 70% of the company's total revenue in 2023. Internationally, SBA's greatest presence is in Brazil, where it operates roughly 10,000 towers. SBA operates as a real estate investment trust.

Share on Social Networks: